Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Monosaccharide-like glycylated sugar alcohol compositions for use as anti-diabetic drugs

A composition and technology for diabetes, which are applied to the application of novel monosaccharide-like glycinated sugar alcohol compositions in the design and development of anti-diabetic drugs, and can solve the problems of unsafe drugs/substances or sugar substitutes and the like

Inactive Publication Date: 2017-02-15
林希龙 +1
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] In conclusion, there is currently no safe drug / medicine or sugar substitute in the management of type 2 diabetes while maintaining normal body energy supply

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Monosaccharide-like glycylated sugar alcohol compositions for use as anti-diabetic drugs
  • Monosaccharide-like glycylated sugar alcohol compositions for use as anti-diabetic drugs
  • Monosaccharide-like glycylated sugar alcohol compositions for use as anti-diabetic drugs

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0042] In the following experimental disclosures, the abbreviations used are as follows: M (mole, molar); mM (millimole, millimolar); μm (micromole, micromolar); mol (mole, moles); ear, picomole); gm (gram, grams); mg (milligram, milligrams); μg (microgram, micrograms); ng (nanogram, nanograms); L (liter, liters); ml (milliliter, milliliters); μl ( Microliters, microliters); ℃ (degrees Celsius, degreesCentigrade); RNA (ribonucleic acid, ribonucleic acid); DNA (deoxyribonucleic acid, deoxyribonucleic acid); dNTP (deoxyribonucleoside triphosphate, deoxyribonucleotide triphosphate); PBS (phosphate Buffer, phosphate buffered saline); NaCl (sodium chloride, sodium chloride); HEPES (N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid, N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid); HBS (HEPES buffer, HEPES buffered saline); SDS (sodium dodecyl sulfate, sodiumdodecylsulfate); Tris-HCl (tris-hydroxymethylaminomethane-hydrochloride, tris-hydroxymethylaminomethane-hydrochloride); AT...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

This invention is related to a sugar-like chemical composition for use in diabetes therapy. Particularly, the present invention teaches the use of monosaccharide-like glycylated sugar alcohol compounds to block or reduce sugar absorption in diabetes patients, so as to prevent the risk of hyperglycemia symptoms. The novelty of the present invention is that glycylated sugar alcohols were found to be useful for treating Diabetes mellitus. In addition, the present application discloses a method for producing these glycylated sugar alcohols. In sum, the present invention includes not only a kind of sugar-like chemical composition for use in treating diabetes but also discloses a state-of-the-art protocol and methodology for producing such a composition via glycylation of sugars and sugar alcohols.

Description

[0001] inventor: [0002] Lin Xilong (Arcadia, CA), Lin Yixiu (Arcadia, CA), Lin Yixiu (Irvine, CA), and Zhang Qinci (Cerritos, CA). [0003] priority: [0004] The present invention claims the U.S. Provisional Application No. 61 / 931,650 filed on January 26, 2014, entitled "Composition and Formulation of Sugar-Alcohol Complex for In vitro and In vivo Delivery of Nucleic Acid Drugs" as its priority. This application also claims priority to U.S. Provisional Application No. 62 / 050,107, filed September 13, 2014, entitled "Novel Monosaccharide-like Glycinated Sugar Alcohol Compositions for the Treatment of Diabetes" . The present invention also claims priority to US Application No. 14 / 457,829, filed August 12, 2014, entitled "Novel Sugar Alcohol-Based Compositions for In vivo and In Vitro Delivery of Nucleic Acid-Based Drugs." This application also claims priority to US Application No. 62 / 054,981, filed September 25, 2014, entitled "Novel Monosaccharide-like Glycinated Sugar Alco...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/223A61K31/7032A61K8/41A61K8/60A61P3/04A61P3/10A61Q19/06
CPCA61K31/7032A61P3/04A61P3/10
Inventor 林希龙林羿秀林怡彣张钦次
Owner 林希龙
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com